Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avricore Health Inc. V.AVCR

Alternate Symbol(s):  AVCRF

Healthcare Diagnostics & Research
Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company’s goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.

Recent & Breaking News (TSXV:AVCR)

Avricore Health Corporate Update and Audited Results for 2023

GlobeNewswire April 30, 2024

HealthTab(TM) Signs Agreement for More Rexall® Pharmacy Locations

GlobeNewswire April 4, 2024

Avricore Health Corporate Update - Company Demonstrates Strong Growth

GlobeNewswire November 30, 2023

HealthTab(TM) Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic

GlobeNewswire September 15, 2023

Avricore Health Corporate Update - Mid-Year Review Demonstrates Company on Right Track

GlobeNewswire August 30, 2023

HealthTab(TM) Signs Reseller Agreement With Abbott to Support UK Expansion

GlobeNewswire August 8, 2023

Avricore's HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom

GlobeNewswire August 3, 2023

HealthTab(TM) to Integrate CONTOUR®NEXT Family of Blood Glucose Meters to Offer Deeper Diabetes Patient Insights

GlobeNewswire July 19, 2023

Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members

GlobeNewswire June 21, 2023

Avricore Grants Options

GlobeNewswire May 15, 2023

Avricore Health Corporate Updates on Audited Results for 2022

GlobeNewswire May 2, 2023

Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection

GlobeNewswire March 23, 2023

Avricore Health Makes the Grade on 2023 TSX Venture 50

GlobeNewswire February 21, 2023

Avricore Health Corporate Update - Earnings Advisory 2022 and 2023 Objectives

GlobeNewswire February 1, 2023

Avricore Health Reports Third-Quarter 2022 Results

GlobeNewswire November 29, 2022

Avricore to Present at Emerging Growth Conference on Oct. 26, 2022

GlobeNewswire October 21, 2022

HealthTab(TM) Roll Out on Track and Operations Cashflow Positive

GlobeNewswire October 11, 2022

Avricore Health Announces CEO Update Call on Sept. 22, 2022

GlobeNewswire September 20, 2022

Avricore Health Supports the Globe and Mail's Health Innovation Event

GlobeNewswire September 19, 2022

Avricore Health Reports Second-Quarter 2022 Results

GlobeNewswire August 29, 2022